Sunday, May 28, 2006

Lymphscintigraphic evaluation of manual lymphatic drainage for lower extremity lymphedema.

March 2006

Kafejian-Haddad AP, Perez JM, Castiglioni ML, Miranda Junior F, de Figueiredo LF.

Vascular Surgery Department, "ABC" Medical School, Sao Paulo, Brazil. apkh@uol.com.br

To evaluate the effect of manual lymphatic drainage on technetium-99m-labeled dextran (99mTcDx) transport, 16 patients with lymphedema of lower extremities underwent two lymphscintigraphy exams by injecting 99mTcDx intradermally into the first interdigital space of the affected extremity. The first was a control examination at rest followed by an examination which included a manual lymphatic drainage session after the injection of the 99mTcDx. Images were obtained 45 minutes and three hours after the injection of the radioisotope.

Extremity volumes were also measured before and after the drainage session. The findings from the examinations were assessed in a quantitative, semiquantitative and qualitative manner and compared without and with drainage. The analyses of the extremities' circumference before and after the drainage by paired t-test revealed a significant decrease. The analyses of the quantitative, semi-quantitative and qualitative evaluations evidenced no significant difference, without or with drainage, within the 45-minute and three-hour periods.

Thus, manual lymphatic drainage caused an effective reduction in the circumference of the extremities but did not have a significant effect in the transport of 99mTcDx.PMID: 16724509 [PubMed - in process]

From Lymphology

Related Abstracts

Assessment of leg oedema by dynamic lymphoscintigraphy with intradermal injection of technetium-99m human serum albumin and load produced by standing.

*

Lymphoscintigraphic drainage of acral limb skin to interval sentinel lymph nodes in healthy subjects.

*

Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma.

*

Lymphatic drainage to the popliteal basin in distal lower extremity malignant melanoma.

No comments: